PHIO logo

Phio Pharmaceuticals (PHIO) Company Overview

Profile

Full Name:

Phio Pharmaceuticals Corp.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

May 10, 2012

Indexes:

Not included

Description:

Phio Pharmaceuticals is a biotechnology company focused on developing innovative therapies for cancer and other diseases. They use a unique platform to enhance the effectiveness of immune treatments, aiming to improve patient outcomes and provide new options for difficult-to-treat conditions.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

May 13, 2021

Recent annual earnings:

Mar 25, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jul 5, 2024

Analyst ratings

Recent major analysts updates

Feb 19, 25 HC Wainwright & Co.
Buy
May 14, 24 HC Wainwright & Co.
Buy
Feb 6, 24 HC Wainwright & Co.
Buy
Aug 16, 23 HC Wainwright & Co.
Buy
Jun 14, 21 HC Wainwright & Co.
Buy
Nov 25, 20 HC Wainwright & Co.
Buy
Aug 5, 20 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Phio Pharmaceuticals?
  • Does Phio Pharmaceuticals pay dividends?
  • What sector is Phio Pharmaceuticals in?
  • What industry is Phio Pharmaceuticals in?
  • What country is Phio Pharmaceuticals based in?
  • When did Phio Pharmaceuticals go public?
  • Is Phio Pharmaceuticals in the S&P 500?
  • Is Phio Pharmaceuticals in the NASDAQ 100?
  • Is Phio Pharmaceuticals in the Dow Jones?
  • When was Phio Pharmaceuticals's last earnings report?
  • When does Phio Pharmaceuticals report earnings?
  • Should I buy Phio Pharmaceuticals stock now?

What is the ticker symbol for Phio Pharmaceuticals?

The ticker symbol for Phio Pharmaceuticals is NASDAQ:PHIO

Does Phio Pharmaceuticals pay dividends?

No, Phio Pharmaceuticals does not pay dividends

What sector is Phio Pharmaceuticals in?

Phio Pharmaceuticals is in the Healthcare sector

What industry is Phio Pharmaceuticals in?

Phio Pharmaceuticals is in the Biotechnology industry

What country is Phio Pharmaceuticals based in?

Phio Pharmaceuticals is headquartered in United States

When did Phio Pharmaceuticals go public?

Phio Pharmaceuticals's initial public offering (IPO) was on May 10, 2012

Is Phio Pharmaceuticals in the S&P 500?

No, Phio Pharmaceuticals is not included in the S&P 500 index

Is Phio Pharmaceuticals in the NASDAQ 100?

No, Phio Pharmaceuticals is not included in the NASDAQ 100 index

Is Phio Pharmaceuticals in the Dow Jones?

No, Phio Pharmaceuticals is not included in the Dow Jones index

When was Phio Pharmaceuticals's last earnings report?

Phio Pharmaceuticals's most recent earnings report was on May 13, 2021

When does Phio Pharmaceuticals report earnings?

The date for Phio Pharmaceuticals's next earnings report has not been announced yet

Should I buy Phio Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions